No ethical divide between China and the West in human embryo research

Developing World Bioethics
Xiaomei ZhaiReidar Lie

Abstract

This is a discussion of the reaction to the recent research article publication in the journal Protein & Cell by a group of scientists at Sun Yat-sen University using the CRISPR/Cas9 technique on editing non-viable human zygotes. Many commentators condemned the Chinese scientists for overstepping ethical boundaries long accepted in Western countries and accused China of having lax regulations on genomic research in general. We argue that not only did this research follow strict ethical standards and fully comply with current regulations, but China also has a well-developed regulatory framework governing such research comparable to many developed countries. We see the reactions among Western commentators as a misunderstanding of the current situation and an expression of a lack of willingness to acknowledge China as an equal partner in the international debate about proper limits to the development of new biotechnologies.

Citations

Jan 20, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Veronica Lau, James R Davie
Dec 26, 2017·Tissue Engineering and Regenerative Medicine·Benjamin PattersonIn-Hyun Park
Mar 24, 2020·British Journal of Sports Medicine·Kumpei TanisawaYannis Pitsiladis
Oct 5, 2020·Biotechnology and Applied Biochemistry·Ruipeng Lei, Renzong Qiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Related Papers

JAMA : the Journal of the American Medical Association
M A Shampo, R A Kyle
Nederlands tijdschrift voor geneeskunde
A S Relman
Journal of the American Podiatric Medical Association
W S Joseph
© 2022 Meta ULC. All rights reserved